PG
Procter and Gamble
Company identity has not yet been verified
See the trials and registry edits we have linked to this sponsor, the company or organization running a study. Choose “Follow company” to add it to your watchlist and find its recorded changes in your dashboard.
3Trials in this database
0Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity source| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI)NCT00091637 | Procter and Gamble | Phase 3 | Completed | 2007-05Actual |
| A Prospective Clinical Trial to Evaluate the Efficacy and Safety of Neurotropic B-Vitamins in Clinically Diagnosed Peripheral Sensory Polyneuropathy of Different Etiologies.NCT05619328 | Procter and Gamble | Phase 3 | Completed | 2023-11-02Actual |
| Assessing Gingivitis of 3 Different Dentifrices Compared to a Negative Control.NCT06892834 | Procter and Gamble | Phase 2 | Completed | 2025-06-19Actual |
Latest recorded trial changes
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.